Advanced SearchSearch Tips
Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 49, Issue 3,  2016, pp.167-172
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2016.49.3.151
 Title & Authors
Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells
Zhou, Lin; Zhong, Yan; Yang, Fang-hui; Li, Zi-bo; Zhou, Jiang; Liu, Xie-hong; Li, Min; Hu, Fang;
  PDF(new window)
Kaiso is a Pox Virus and Zinc Finger (POZ-ZF) transcription factor with bi-modal DNA-binding specificity. Here, we demonstrated that Kaiso expression is inversely correlated with glucocorticoid receptor (GR) expression in breast carcinomas. Knockdown of Kaiso increased GR expression, while overexpression of Kaiso inhibited GR expression in breast cancer cells. Furthermore, Kaiso repressed GR proximal promoter-reporter activity in a dose-dependent manner. Remarkably, ChIP experiments demonstrated that endogenous Kaiso was associated with the GR promoter sequence in a methylation-dependent manner. Since glucocorticoids inhibit chemotherapyinduced apoptosis and have been widely used as a co-treatment of patients with breast cancer, we assessed the role of Kasio in GR-mediated anti-apoptotic effects. We found that overexpression of Kaiso attenuated the anti-apoptotic effects of glucocorticoids in breast cancer cells. Our findings suggest that GR is a putative target gene of Kaiso and suggest Kaiso to be a potential therapeutic target in GC-combination chemotherapy in breast cancer.
Breast cancer;Epigenetics;Glucocorticoid receptor;Kaiso;
 Cited by
Possible roles for glucocorticoid signalling in breast cancer, Molecular and Cellular Endocrinology, 2017  crossref(new windwow)
Daniel JM and Reynolds AB (1999) The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 19, 3614-3623 crossref(new window)

Daniel JM, Spring CM, Crawford HC, Reynolds AB and Baig A (2002) The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res 30, 2911-2919 crossref(new window)

Ruzov A, Dunican DS, Prokhortchouk A et al. (2004) Kaiso is a genome-wide repressor of transcription that is essential for amphibian development. Development 131, 6185-6194 crossref(new window)

Donaldson NS, Nordgaard CL, Pierre CC et al (2010) Kaiso regulates Znf131-mediated transcriptional activation. Exp Cell Res 316, 1692-1705 crossref(new window)

Rodova M, Kelly KF, VanSaun M, Daniel JM and Werle MJ (2004) Regulation of the rapsyn promoter by kaiso and delta-catenin. Mol Cell Biol 24, 7188-7196 crossref(new window)

Vermeulen JF, van de Ven RA, Ercan C et al (2012) Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer. PLoS One 7, e37864 crossref(new window)

Jones J, Wang H, Karanam B et al (2014) Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin Exp Metastasis 31, 497-510 crossref(new window)

Conzen SD (2008) Minireview: nuclear receptors and breast cancer. Mol Endocrinol 22, 2215-2228 crossref(new window)

Karmakar S, Jin Y and Nagaich AK (2013) Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) alpha and activator protein 1 (AP1) in dexamethasonemediated interference of ERalpha activity. J Biol Chem 288, 24020-24034 crossref(new window)

Ling J and Kumar R (2012) Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy. Cancer Lett 322, 119-126 crossref(new window)

Vilasco M, Communal L, Mourra N, Courtin A, Forgez P and Gompel A (2011) Glucocorticoid receptor and breast cancer. Breast Cancer Res Treat 130, 1-10 crossref(new window)

Nesset KA, Perri AM and Mueller CR (2014) Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors. Epigenetics 9, 851-859 crossref(new window)

Yemelyanov A, Czwornog J, Chebotaev D et al (2007) Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 26, 1885-1896 crossref(new window)

Chebotaev D, Yemelyanov A, Zhu L, Lavker RM and Budunova I (2007) The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells. Oncogene 26, 3060-3068 crossref(new window)

Kay P, Schlossmacher G, Matthews L et al (2011) Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells. PLoS One 6, e24839 crossref(new window)

Lind GE, Kleivi K, Meling GI et al (2006) ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol 28, 259-272

Mikosz CA, Brickley DR, Sharkey MS, Moran TW and Conzen SD (2001) Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J Biol Chem 276, 16649-16654 crossref(new window)

Machuca C, Mendoza-Milla C, Cordova E et al (2006) Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT. BMC Cell Biol 7, 9 crossref(new window)

Schorr K and Furth PA (2000) Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependent. Cancer Res 60, 5950-5953

Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T and Conzen SD (2004) Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64, 1757-1764 crossref(new window)

Lopes EC, Valls E, Figueroa ME et al (2008) Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines. Cancer Res 68, 7258-7263 crossref(new window)

Turner JD, Alt SR, Cao L et al (2010) Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochem Pharmacol 80, 1860-1868 crossref(new window)

Yoon HG, Chan DW, Reynolds AB, Qin J and Wong J (2003) N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell 12, 723-734 crossref(new window)